Caution is needed when using denosumab: which serious side effects should be closely monitored?
Denosumab is an important biologic agent widely used in the treatment of osteoporosis,giant cell tumors of bone,and bone-related events caused by bone metastasis of solid tumors.By inhibiting the activity and survival of osteoclasts,it effectively increases bone density and reduces the risk of fractures,playing a key role in the treatment of skeletal diseases.Although denosumab has a good overall safety profile,like all drugs,it may also bring some potentially serious side effects,especially in specific situations such as long-term use or individual sensitivity.Therefore,both patients and doctors need to have a full understanding of this so as to identify and manage it in a timely manner.

1.The most serious side effect to be vigilant about:hypocalcemia
Hypocalcemia is one of the most severe and prioritized side effects in the treatment with denosumab.Due to the potential impact of the drug's mechanism of action on calcium metabolic balance,it can lead to excessively low levels of calcium ions in the blood.
Main symptoms:Patients may experience hand and foot twitching,muscle spasms,and sensory abnormalities(such as numbness of lips and fingertips).In severe cases,it can lead to arrhythmias,seizures,and even psychiatric symptoms such as anxiety,depression,or altered consciousness.
High-risk factors and prevention:Patients with vitamin D deficiency,pre-existing hypocalcemia,or renal insufficiency face higher risks before medication.
Countermeasures:
Before medication:It is essential to correct the existing hypocalcemia and vitamin D deficiency.
During medication:Regular monitoring of blood calcium levels is required(usually every 3-6 months)to ensure they remain within the normal range.
Daily supplementation:Ensure adequate intake of calcium(1000-1200mg per day)and vitamin D(800-2000IU per day),with specific dosages to be followed as prescribed by a doctor.
II.Serious complications of the skeletal system worthy of attention
Although denosumab is designed to protect bones,in rare cases,it may still cause the following serious bone problems:
Atypical femoral fracture:
Manifestation:It often occurs without obvious trauma or with only minor external force,presenting with severe pain in the thigh or groin area.X-ray examination may reveal transverse or short oblique fracture lines,commonly occurring in the femoral shaft below the lesser trochanter.
High-risk factors:long-term medication(usually exceeding 3-5 years),concomitant use of corticosteroids,etc.
Oral osteonecrosis(ONJ):
Manifestation:Destruction and exposure of the jawbone(maxilla and mandible),which may be accompanied by pain,swelling,infection,tooth loosening or shedding.Exposed dead bone can be seen from the inside of the mouth.
Inducing factors:dental surgery(such as tooth extraction and dental implant),poor oral hygiene,concurrent use of chemotherapy or glucocorticoids.
Prevention and management:
Conduct a comprehensive oral examination and necessary treatment before administering medication.
Maintain good oral hygiene habits and have regular dental cleanings.
Try to avoid invasive dental procedures.If necessary,inform the dentist that you are currently using Denosumab and may need to temporarily discontinue its use.
In case of symptoms such as oral pain,swelling,and persistent ulcers,it is important to seek medical attention promptly.
III.Increased infection risk
Denosumab may slightly suppress the immune system,thereby increasing the risk of certain infections.
Injection site reactions and infections:The injection site may exhibit redness,swelling,and pain.In rare cases,infection may occur,manifesting as worsening localized redness,swelling,heat,and pain,and even the appearance of abscesses.It is important to keep the injection site clean and dry,and seek medical attention promptly if there are signs of infection.
Severe skin infections:such as cellulitis,abscess,etc.,require active anti-infective treatment.
Infection associated with osteoradionecrosis of the jaw(ONJ):As mentioned earlier,ONJ itself often accompanies infection.
Other opportunistic infections:In patients with compromised immunity,vigilance is needed to prevent the occurrence of infections such as pneumonia.
IV.Anaphylactic reaction
Although rare,denosumab may still induce allergic reactions.
Symptoms:In mild cases,rash,itching,and urticaria may occur;in severe cases,anaphylactic shock manifestations such as difficulty breathing,tightness in the throat,hoarseness,swelling of the face/eyelids/tongue,dizziness,blood pressure decline,and loss of consciousness may occur.
Treatment:In case of suspected allergic reaction,the medication should be discontinued immediately and emergency medical attention should be sought.For severe allergies,emergency medications such as adrenaline should be administered.
V.Potential impact on renal function
Denosumab is primarily metabolized and eliminated by the kidneys,and therefore may exert certain effects on renal function,especially in patients with pre-existing chronic kidney disease,dehydration,or concurrent use of other nephrotoxic drugs.
Monitoring:Before and during medication,doctors may recommend regular monitoring of renal function indicators,such as serum creatinine and estimated glomerular filtration rate(eGFR).
VI.Other side effects to be aware of
In addition to the aforementioned serious side effects,denosumab may also cause some other side effects.Although most of them are relatively mild,they still merit attention if they persist or worsen:
Common reactions:including headache,nausea,diarrhea,constipation,muscle or bone pain,fatigue,etc.
Treatment:These reactions are usually self-limited or can be alleviated through symptomatic treatment.If symptoms persist,worsen,or affect quality of life,consult a doctor promptly.
Summary and Suggestions
Denosumab is a potent drug for improving bone health,but its potential risks cannot be ignored.To ensure safe and effective use of denosumab,patients should pay attention to the following points:
Strictly follow the doctor's advice:Do not increase or decrease the dosage or discontinue the medication on your own.Sudden discontinuation may increase the risk of vertebral fractures.
Full communication:Inform the doctor in detail about your medical history,allergy history,all medications(including health supplements)you are currently taking,and your oral health status.
Regular monitoring:Perform relevant examinations such as blood calcium,vitamin D,renal function,as well as bone density and oral examinations,according to the doctor's requirements.
Pay attention to bodily signals:Be mindful of any discomfort you experience,especially early signs of the aforementioned serious side effects,and communicate with your doctor promptly.
Healthy lifestyle:maintain a balanced diet,ensure adequate intake of calcium and vitamin D,engage in moderate exercise,quit smoking and limit alcohol consumption,and uphold good oral hygiene.
Through the joint efforts of both doctors and patients,with full understanding and active response,the benefits of denosumab can be maximized,while the risk of serious side effects can be minimized,thereby better maintaining patients'bone health and quality of life.
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)